Terrie Curran Arcutis Biotherapeutics, Inc. (ARQT) insider trading activity
Terrie Curran is Director of Arcutis Biotherapeutics, Inc.. Currently has a direct ownership of 18,826 shares of ARQT, which is worth approximately $175,081. The most recent transaction as insider was on Jun 14, 2024, when has been sold 10,139 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
18.8K
116.71%
3M change
116.71%
12M change
Total Value Held
$175,081
Terrie Curran Transaction History
Also insider at
TC
Terrie Curran
Director
Florham Park, NJ